Combined 5-fluorouracil and floxuridine administered as a 14-day infusion. A phase I study.

MLA

Anderson, Norwood, et al. “Combined 5-Fluorouracil and Floxuridine Administered as a 14-Day Infusion. A Phase I Study.” Cancer (0008543X), vol. 63, no. 5, Mar. 1989, pp. 825–27. EBSCOhost, https://doi.org/10.1002/1097-0142(19890301)63:5<825::AID-CNCR2820630505>3.0.CO;2-F.

APA

Anderson, N., Lokich, J., Bern, M., Wallach, S., Moore, C., Williams, D., Umprayn, V., Anderson, N., Lokich, J., Bern, M., Wallach, S., Moore, C., Williams, D., & Umprayn, V. (1989). Combined 5-fluorouracil and floxuridine administered as a 14-day infusion. A phase I study. Cancer (0008543X), 63(5), 825–827. https://doi.org/10.1002/1097-0142(19890301)63:5<825::AID-CNCR2820630505>3.0.CO;2-F

Chicago

Anderson, Norwood, Jacob Lokich, Murray Bern, Sabina Wallach, Cherie Moore, David Williams, Vimonrat Umprayn, et al. 1989. “Combined 5-Fluorouracil and Floxuridine Administered as a 14-Day Infusion. A Phase I Study.” Cancer (0008543X) 63 (5): 825–27. doi:10.1002/1097-0142(19890301)63:5<825::AID-CNCR2820630505>3.0.CO;2-F.